Long-term oncologic outcomes of robotic low anterior resection for rectal cancer

Annals of Surgery

Volumn 261, Issue 1, 2015, Pages 129-137

  Park, Eun Jung ^a   Cho, Min Soo ^a   Baek, Se Jin ^a   Hur, Hyuk ^a   Min, Byung Soh ^a   Baik, Seung Hyuk ^a   Lee, Kang Young ^a   Kim, Nam Kyu ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Laparoscopic surgery; Oncologic outcome; Rectal cancer; Robotic surgery; Total mesorectal excision

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ABDOMINAL ABSCESS; ADULT; ANASTOMOSIS LEAKAGE; ANASTOMOSIS STENOSIS; ARTICLE; ASCITES; ASTHMA; BLADDER INJURY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHYLOUS ASCITES; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; ILEUS; INCISIONAL HERNIA; INTERMETHOD COMPARISON; ISCHEMIC COLITIS; LAPAROSCOPIC SURGERY; LEARNING CURVE; LONG TERM CARE; LONG TERM SURVIVAL; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PEROPERATIVE COMPLICATION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; RECTUM CANCER; RECTUM PERFORATION; RECURRENCE RISK; RETROGRADE EJACULATION; ROBOT ASSISTED SURGERY; SURVIVAL RATE; TISSUE ADHESION; TUMOR INVASION; WOUND INFECTION; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; AGED; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; LAPAROSCOPY; LENGTH OF STAY; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RECTAL NEOPLASMS; ROBOTICS; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; ROBOTICS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84927170070     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000613     Document Type: Article

References (31)

1. Buunen M, Veldkamp R, Hop WC, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2009; 10: 44-52.
2. Laurent C, Leblanc F, Wutrich P, et al. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results. Ann Surg. 2009; 250: 54-61.
3. Nelson H, Sargent DJ, Wieand HS, et al. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004; 350: 2050-2059.
4. Fleshman J, Sargent DJ, Green E, et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg. 2007; 246: 655-662; discussion 662-664.
5. Green BL, Marshall HC, Collinson F, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013; 100: 75-82.
6. Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010; 97: 1638-1645.
7. Bretagnol F, Lelong B, Laurent C, et al. The oncological safety of laparoscopic totalmesorectal excision with sphincter preservation for rectal carcinoma. Surg Endosc. 2005; 19: 892-896.
8. Ballantyne GH. The pitfalls of laparoscopic surgery: challenges for robotics and telerobotic surgery. Surg Laparosc Endosc Percutan Tech. 2002; 12: 1-5.
9. D'Annibale A, Pernazza G, Monsellato I, et al. Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc. 2013; 27: 1887-1895.
10. Baik SH, Kim NK, Lim DR, et al. Oncologic outcomes and perioperative clinicopathologic results after robot-assisted tumor-specific mesorectal excision for rectal cancer. Ann Surg Oncol. 2013; 20: 2625-2632.
11. Kwak JM, Kim SH, Kim J, et al. Robotic vs laparoscopic resection of rectal cancer: short-term outcomes of a case-control study. Dis Colon Rectum. 2011; 54: 151-156.
12. Baek JH, Pastor C, Pigazzi A. Robotic and laparoscopic total mesorectal excision for rectal cancer: a case-matched study. Surg Endosc. 2011; 25: 521-525.
13. Bianchi PP, Ceriani C, Locatelli A, et al. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surg Endosc. 2010; 24: 2888-2894.
14. Park SY, Choi GS, Park JS, et al. Short-term clinical outcome of robot-assisted intersphincteric resection for lowrectal cancer: a retrospective comparisonwith conventional laparoscopy. Surg Endosc. 2013; 27: 48-55.
15. Baek SJ, Al-Asari S, Jeong DH, et al. Robotic versus laparoscopic coloanal anastomosis with or without intersphincteric resection for rectal cancer. Surg Endosc. 2013; 27: 4157-4163.
16. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993; 341: 457-460.
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240: 205-213.
18. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994; 344: 707-711.
19. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med. 2000; 124: 1016-1025.
20. Cecil TD, Sexton R, Moran BJ, et al. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum. 2004; 47: 1145-1149.
21. Baik SH, Lee WJ, Rha KH, et al. Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc. 2008; 22: 792-797.
22. Baik SH, Ko YT, Kang CM, et al. Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc. 2008; 22: 1601-1608.
23. Baik SH, Kwon HY, Kim JS, et al. Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Ann Surg Oncol. 2009; 16: 1480-1487.
24. Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial); multicentre, randomised controlled trial. Lancet. 2005; 365: 1718-1726.
25. Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopicassisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007; 25: 3061-3068.
26. Morino M, Parini U, Giraudo G, et al. Laparoscopic total mesorectal excision: a consecutive series of 100 patients. Ann Surg. 2003; 237: 335-342.
27. Tasang WW, Chung CC, Kwok SY, et al. Laparoscopic sphincter-preserving total mesorectal excision with colonic J-pouch reconstruction: five-year result. Ann Surg. 2006; 243: 353-358.
28. Ng SS, Leung KL, Lee JF, et al. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial. Ann Surg Oncol. 2008; 15: 2418-2425.
29. Baik SH, Gincherman M, Mutch MG, et al. Laparoscopic vs. open resection for patients with rectal cancer: comparison of perioperative outcomes and long-term survival. Dis Colon Rectum. 2011; 54: 6-14.
30. Baek JH, McKenzie S, Garcia-Aguilar J, et al. Oncologic outcomes of roboticassisted total mesorectal excision for the treatment of rectal cancer. Ann Surg. 2010; 251: 882-886.
31. Pigazzi A, Luca F, Patriti A, et al. Multicentric study on robotic tumorspecific mesorectal excision for the treatment of rectal cancer. Ann Surg Oncol. 2010; 17: 1614-1620.